BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screening.
Am J Cancer Res
; 9(11): 2428-2441, 2019.
Article
in En
| MEDLINE
| ID: mdl-31815044
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Screening_studies
Language:
En
Journal:
Am J Cancer Res
Year:
2019
Document type:
Article
Affiliation country:
United States